These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2297644)

  • 21. Prognostic significance of tumor grade and stage in the patient with carcinoma of the prostate.
    Grayhack JT; Assimos DG
    Prostate; 1983; 4(1):13-31. PubMed ID: 6340082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
    Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ
    J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate carcinoma--the value of T stage and grade in predicting metastases and prognosis. A cost-effective approach to clinical staging.
    Allen FJ; de Kock ML; de Klerk DP; Heyns CF
    S Afr J Surg; 1991 Mar; 29(1):15-8. PubMed ID: 1905062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy.
    Cadeddu JA; Partin AW; Epstein JI; Walsh PC
    Urology; 1997 Aug; 50(2):251-5. PubMed ID: 9255297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation between histologic grading and prognosis of prostatic cancer--comparing the grading system of the Japanese general rules of prostatic cancer with Gleason's grading].
    Hioki T; Sugimura Y; Sakurai M; Hayashi N; Tochigi H; Kawamura J; Yatani R
    Hinyokika Kiyo; 1990 Aug; 36(8):921-6. PubMed ID: 2239593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study.
    Shou J; Zhang Q; Wang S; Zhang D
    Prostate; 2018 May; 78(7):491-497. PubMed ID: 29436722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of patients with prostate carcinoma presenting as nonregional lymph node metastases.
    Furuya Y; Akakura K; Akimoto S; Ito H
    Urol Int; 1998 Oct; 61(1):17-21. PubMed ID: 9792977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement.
    Pagano F; Bassi P; Ferrante GL; Piazza N; Abatangelo G; Pappagallo GL; Garbeglio A
    J Urol; 1996 Jan; 155(1):244-7. PubMed ID: 7490845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival with skin metastases from carcinoma of prostate.
    Marquis W; Benson R
    Urology; 1980 Oct; 16(4):407-8. PubMed ID: 7414790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deferred treatment in clinically localised prostatic carcinoma.
    Adolfsson J; Carstensen J; Löwhagen T
    Br J Urol; 1992 Feb; 69(2):183-7. PubMed ID: 1537031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis in stage D-1 prostate cancer relative to anatomic sites of nodal metastases. National Prostatic Cancer Treatment Group.
    Schmidt JD; Gibbons RP; Bartolucci A; Murphy GP
    Cancer; 1989 Oct; 64(8):1743-6. PubMed ID: 2790688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization.
    Gburek BM; Kollmorgen TA; Qian J; D'Souza-Gburek SM; Lieber MM; Jenkins RB
    J Urol; 1997 Jan; 157(1):223-7. PubMed ID: 8976257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of poorly differentiated prostatic adenocarcinoma.
    El-Mahdi AM; Oliphant LD; Schellhammer PF
    Urology; 1983 Jun; 21(6):566-9. PubMed ID: 6868227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic values of clinicopathological characteristics and survival outcomes in prostate infiltrating ductal carcinoma: a population-based study.
    Wu YP; Chen SH; Wang ST; Li XD; Cai H; Lin YZ; Xue XY; Wei Y; Zheng QS; Xu N
    Oncotarget; 2017 Apr; 8(17):29048-29055. PubMed ID: 28423709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of pulmonary metastases in stage D2 prostate cancer patients.
    Nakamachi H; Suzuki H; Akakura K; Imamoto T; Ueda T; Ishihara M; Furuya Y; Ichikawa T; Igarashi T; Ito H
    Prostate Cancer Prostatic Dis; 2002; 5(2):159-63. PubMed ID: 12497007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Staging pelvic lymphadenectomy for carcinoma of the prostate].
    Rinsho K; Ishikawa S; Nemoto R; Koiso K; Takeshima H; Uchida K
    Hinyokika Kiyo; 1985 Sep; 31(9):1583-7. PubMed ID: 4083215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostatic carcinoma: staging with MR imaging at 1.5 T.
    Bezzi M; Kressel HY; Allen KS; Schiebler ML; Altman HG; Wein AJ; Pollack HM
    Radiology; 1988 Nov; 169(2):339-46. PubMed ID: 3174982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Staging pelvic lymphadenectomy for carcinoma of the prostate: review of 23 cases].
    Arai Y; Taniguchi T; Kaku S; Kihara Y; Okada K; Kawamura J
    Hinyokika Kiyo; 1986 Mar; 32(3):401-6. PubMed ID: 3728242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of incidental carcinoma of the prostate. II. Nuclear DNA analysis].
    Fujita T; Akino H; Kanimoto Y; Okada K; Shiraishi T; Nakakuki K
    Hinyokika Kiyo; 1991 Sep; 37(9):1009-16. PubMed ID: 1785407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.